Endi mavjud! Telegram Tadqiqoti 2025 — yilning asosiy insaytlari 
JAMA (Journal of the American Medical Association)
Kanalga Telegram’da o‘tish
All the latest articles published on JAMA before going in to print Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot
Ko'proq ko'rsatish📈 Telegram kanali JAMA (Journal of the American Medical Association) analitikasi
JAMA (Journal of the American Medical Association) (@jamaupdates) Ingliz til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 15 181 obunachidan iborat bo'lib, Tibbiyot toifasida 1 625-o'rinni va AQSH mintaqasida 2 525-o'rinni egallagan.
📊 Auditoriya ko‘rsatkichlari va dinamika
невідомо sanasidan buyon loyiha tez o‘sib, 15 181 obunachiga ega bo‘ldi.
11 Iyun, 2026 dagi oxirgi ma’lumotlarga ko‘ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 535 ga, so‘nggi 24 soatda esa 12 ga o‘zgardi va umumiy qamrov yuqori darajada qolmoqda.
- Tasdiqlash holati: Tasdiqlanmagan
- Jalb etish (ER): Auditoriya o‘rtacha 4.53% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 2.35% ini tashkil etuvchi reaksiyalarni to‘playdi.
- Post qamrovi: Har bir post o‘rtacha 687 marta ko‘riladi; birinchi sutkada odatda 356 ta ko‘rish yig‘iladi.
- Reaksiyalar va o‘zaro ta’sir: Auditoriya faol: har bir postga o‘rtacha 1 ta reaksiya keladi.
- Tematik yo‘nalishlar: Kontent patient, disease, treatment, drug, guideline kabi asosiy mavzularga jamlangan.
📝 Tavsif va kontent siyosati
Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida ta’riflaydi:
“All the latest articles published on JAMA before going in to print
Discussion Group
https://t.me/Medical_Professionals_Forum
Contact us
https://t.me/Contact_Updates_in_Medicine_Bot”
Yuqori yangilanish chastotasi (oxirgi ma’lumot 12 Iyun, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli bo‘lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim ta’sir nuqtasiga aylantirishini ko‘rsatadi.
15 181
Obunachilar
+1224 soatlar
+1077 kunlar
+53530 kunlar
Ma'lumot yuklanmoqda...
O'xshash kanallar
Taglar buluti
Kirish va chiqish esdaliklari
---
---
---
---
---
---
Obunachilarni jalb qilish
Iyun '26
Iyun '26
+173
0 kanalda
May '26
+584
0 kanalda
Get PRO
Aprel '26
+437
0 kanalda
Get PRO
Mart '26
+217
0 kanalda
Get PRO
Fevral '26
+247
0 kanalda
Get PRO
Yanvar '26
+321
0 kanalda
Get PRO
Dekabr '25
+277
0 kanalda
Get PRO
Noyabr '25
+366
2 kanalda
Get PRO
Oktabr '25
+164
0 kanalda
Get PRO
Sentabr '25
+12
0 kanalda
Get PRO
Avgust '25
+29
0 kanalda
Get PRO
Iyul '25
+30
0 kanalda
Get PRO
Iyun '25
+17
0 kanalda
Get PRO
May '25
+9
0 kanalda
Get PRO
Aprel '25
+5
0 kanalda
Get PRO
Mart '25
+17
0 kanalda
Get PRO
Fevral '25
+12
0 kanalda
Get PRO
Yanvar '25
+18
1 kanalda
Get PRO
Dekabr '24
+237
0 kanalda
Get PRO
Noyabr '24
+1 122
0 kanalda
Get PRO
Oktabr '24
+1 120
0 kanalda
Get PRO
Sentabr '24
+1 527
1 kanalda
Get PRO
Avgust '24
+1 128
1 kanalda
Get PRO
Iyul '24
+1 216
0 kanalda
Get PRO
Iyun '24
+781
1 kanalda
Get PRO
May '24
+797
1 kanalda
Get PRO
Aprel '24
+808
1 kanalda
Get PRO
Mart '24
+821
2 kanalda
Get PRO
Fevral '24
+753
1 kanalda
Get PRO
Yanvar '24
+768
0 kanalda
Get PRO
Dekabr '23
+716
1 kanalda
Get PRO
Noyabr '23
+96
1 kanalda
Get PRO
Oktabr '23
+86
0 kanalda
Get PRO
Sentabr '23
+73
0 kanalda
Get PRO
Avgust '23
+90
0 kanalda
Get PRO
Iyul '23
+107
0 kanalda
Get PRO
Iyun '23
+105
0 kanalda
Get PRO
May '23
+169
0 kanalda
Get PRO
Aprel '23
+128
0 kanalda
Get PRO
Mart '23
+84
0 kanalda
Get PRO
Fevral '23
+75
0 kanalda
Get PRO
Yanvar '23
+71
0 kanalda
Get PRO
Dekabr '22
+74
0 kanalda
Get PRO
Noyabr '22
+149
0 kanalda
Get PRO
Oktabr '22
+90
0 kanalda
Get PRO
Sentabr '22
+138
0 kanalda
Get PRO
Avgust '22
+77
0 kanalda
Get PRO
Iyul '22
+50
0 kanalda
Get PRO
Iyun '22
+96
0 kanalda
Get PRO
May '22
+75
0 kanalda
Get PRO
Aprel '22
+80
0 kanalda
Get PRO
Mart '22
+65
0 kanalda
Get PRO
Fevral '22
+26
0 kanalda
Get PRO
Yanvar '22
+56
0 kanalda
Get PRO
Dekabr '21
+44
0 kanalda
Get PRO
Noyabr '21
+39
0 kanalda
Get PRO
Oktabr '21
+61
0 kanalda
Get PRO
Sentabr '21
+66
0 kanalda
Get PRO
Avgust '21
+65
0 kanalda
Get PRO
Iyul '21
+96
0 kanalda
Get PRO
Iyun '21
+120
0 kanalda
Get PRO
May '21
+130
0 kanalda
Get PRO
Aprel '21
+812
0 kanalda
| Sana | Obunachilarni jalb qilish | Esdaliklar | Kanallar | |
| 12 Iyun | +5 | |||
| 11 Iyun | +12 | |||
| 10 Iyun | +23 | |||
| 09 Iyun | +9 | |||
| 08 Iyun | +8 | |||
| 07 Iyun | +18 | |||
| 06 Iyun | +13 | |||
| 05 Iyun | +25 | |||
| 04 Iyun | +22 | |||
| 03 Iyun | +9 | |||
| 02 Iyun | +19 | |||
| 01 Iyun | +10 |
Kanal postlari
Sodium Bicarbonate for In-Hospital Cardiac Arrest Research Summary
https://jamanetwork.com/journals/jama/fullarticle/2850404
This study aimed to determine if sodium bicarbonate administered during in-hospital cardiac arrest increases the rate of sustained return of spontaneous circulation.
| 2 | Sodium Bicarbonate for In-Hospital Cardiac Arrest
https://jamanetwork.com/journals/jama/fullarticle/2850405
This randomized clinical trial examines whether administration of sodium bicarbonate during in-hospital cardiac arrest increases return of spontaneous circulation as well as survival and survival with a favorable neurologic outcome. | 369 |
| 3 | Will the Bicarbonate for In-Hospital Cardiac Arrest Trial Change Practice?
https://jamanetwork.com/journals/jama/fullarticle/2850406
In this issue of JAMA, Granfeldt and colleagues share results of the Bicarbonate for In-Hospital Cardiac Arrest randomized clinical trial comparing routine administration of sodium bicarbonate with placebo during attempted resuscitation of 779 patients with in-hospital cardiac arrest. The physiological rationale for administering sodium bicarbonate is to temporarily reduce the profound metabolic acidosis that develops during cardiac arrest to reverse myocardial depression and improve catecholamine action. Sodium bicarbonate is hypertonic and may increase intravascular volume. The primary outcome of return of spontaneous circulation was not different after sodium bicarbonate (39%) relative to placebo (37%). The intervention also did not change secondary outcomes, including organ dysfunction in the first 72 hours, 30-day survival (12% vs 9%), functional scores, or quality-of-life scores. Among patients who survived, those in the sodium bicarbonate group had higher pH and blood bicarbonate values, demonstrating successful delivery of the intervention. | 359 |
| 4 | Two Years of Menaquinone-7 Supplementation and Coronary Artery Calcification
https://jamanetwork.com/journals/jamacardiology/fullarticle/2850256
This randomized clinical trial evaluates the progression of coronary artery calcification compared with placebo over a 2-year period. | 467 |
| 5 | Coronary Artery Calcium Progression—A Useful Outcome in Clinical Trials?
https://jamanetwork.com/journals/jamacardiology/fullarticle/2850257
In this issue of JAMA Cardiology, Vossen et al report the results of a randomized clinical trial investigating whether supplementation with the vitamin K homologue menaquinone-7 (MK-7) at a daily dose of 360 µg would delay progression of coronary artery calcification. Among 180 patients with baseline coronary artery calcium (CAC) scores of 50 to 400 Agatston units (AU), they observed a small but statistically significant slowing of CAC progression, measured as either AU or calcium mass score. | 451 |
| 6 | Cost Offset With Quadruple Therapy for Heart Failure
https://jamanetwork.com/journals/jamacardiology/fullarticle/2850258
This economic evaluation examines Medicare-linked registry data to estimate the 1-year health care cost offset and net cost associated with using quadruple guideline-directed medical therapy after hospitalization for heart failure with reduced ejection fraction. | 425 |
| 7 | Neurological Manifestations in Adult Survivors of Ebola Virus Disease
https://jamanetwork.com/journals/jamaneurology/fullarticle/2850237
This cohort study evaluates the neurological health of adult survivors of Ebola virus disease over the course of a 7-year follow-up. | 436 |
| 8 | High-Dose Intravenous Vitamin C and Mortality and Organ Dysfunction in Severe Burn Injury Research Summary
https://jamanetwork.com/journals/jama/fullarticle/2850391
The objective of this study was to determine whether high-dose intravenous vitamin C improves a composite of 28-day mortality and persistent organ dysfunction in patients with severe burn injury. | 530 |
| 9 | High-Dose Intravenous Vitamin C in Severe Burn Injury
https://jamanetwork.com/journals/jama/fullarticle/2850392
This international randomized clinical trial evaluates the efficacy of high-dose intravenous vitamin C in reducing 28-day mortality and persistent organ dysfunction (dependence on mechanical ventilation, kidney replacement therapy, or vasopressor/inotrope support at day 28) in patients with severe burn injury. | 524 |
| 10 | High-Dose Vitamin C in Burns
https://jamanetwork.com/journals/jama/fullarticle/2850393
In this issue of JAMA, Stoppe and colleagues present the results of an international randomized clinical trial that provides evidence that high-dose intravenous vitamin C does not improve outcomes in patients with large burns. The data from the VICTORY trial even suggest that use of vitamin C in patients with large burns might increase mortality. This well-designed study had strict criteria for stopping based on futility or harm. It is clear that the possibility of vitamin C improving outcomes in major burns is extremely low. | 487 |
| 11 | Personalized Blood Pressure Targeting After Endovascular Therapy for Acute Ischemic Stroke
https://jamanetwork.com/journals/jamaneurology/fullarticle/2850074
This randomized clinical trial evaluates whether a reperfusion-guided systolic blood pressure control strategy improves functional outcomes compared with guideline-recommended management after successful endovascular therapy for acute ischemic stroke. | 685 |
| 12 | Pathology and Genetics in a Global Cohort of Parkinsonian Disorders
https://jamanetwork.com/journals/jamaneurology/fullarticle/2850075
This cross-sectional study investigates how genetic variants and neuropathology are associated with clinical features and diagnostic accuracy in movement disorders. | 646 |
| 13 | Self-Reported Seizure Durations
https://jamanetwork.com/journals/jamaneurology/fullarticle/2850076
This cohort study examines the range of self-reported seizure durations from more than 18 000 children and adults. | 591 |
| 14 | Missing Funding/Support and Role of the Funder Statement
https://jamanetwork.com/journals/jamaneurology/fullarticle/2850077
In the Original Investigation titled “Phenoconversion in Pure Autonomic Failure: A Systematic Review and Meta-Analysis,” published online on May 4, 2026, the Funding/Support and Role of the Funder/Sponsor acknowledgments were missing in the Article Information. The work was funded by a grant from Parkinson’s UK. This information has been added, in addition to the Role of the Funder/Sponsor. This article has been corrected online. | 555 |
| 15 | Survivors of Cyanotic Congenital Heart Disease: A Review
https://jamanetwork.com/journals/jama/fullarticle/2850177
This Review discusses the pathophysiology of cardiovascular complications in adults with cyanotic congenital heart disease after early management and examines late complications and management strategies. | 526 |
| 16 | Evaluating Inflammatory Joint Pain in Older Adults
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2850108
This Clinical Insights discusses inflammatory arthritis in older adults and offers practical guidance. | 538 |
| 17 | Cognition After Postoperative Delirium
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2850109
Postoperative delirium is common in older adults, but some of its long-term consequences remain debated. Its association with adverse outcomes is well established, including longer hospital stays, functional decline, institutionalization, and mortality. A more challenging question is whether delirium itself contributes to later cognitive decline or if it mainly identifies patients who already have frailty, have a health record that is medically complex, and are likely to become ill again. These competing explanations have distinct implications for care, including what we tell patients and families at discharge, how we plan follow-up, and how much emphasis we place on delirium prevention. In this issue of JAMA Internal Medicine, Hshieh et al provide data that help advance this debate. | 532 |
| 18 | Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity Research Summary
https://jamanetwork.com/journals/jama/fullarticle/2850142
This study evaluated whether a once-weekly, 9-mg dose of mazdutide (combined with a reduced calorie diet and increased physical activity) leads to effective and safe weight reduction in Chinese adults with obesity (body mass index [BMI] ≥30) compared with placebo. | 623 |
| 19 | Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity
https://jamanetwork.com/journals/jama/fullarticle/2850143
This randomized clinical trial compares the efficacy and safety of a 9-mg dose of mazdutide vs placebo in Chinese adults with obesity. | 606 |
| 20 | Insulin Costs and Use After the Inflation Reduction Act Out-of-Pocket Cap
https://jamanetwork.com/journals/jama/fullarticle/2850128
This interrupted time series analysis uses Medicare Part D data from January 2021 through December 2023 to measure changes in insulin cost and use after the Inflation Reduction Act $35 cap on out-of-pocket insulin costs, overall and for insulin users with previously high out-of-pocket cost. | 771 |
